Gilbert, Christopher L <br/><br/>
Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.  [electronic resource] 

 -  Vaccine  Nov 2014 
 - 6521-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2014.09.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibody Formation<br/>Double-Blind Method<br/>Female<br/>Hepatitis B--prevention & control<br/>Hepatitis B Antibodies--blood<br/>Hepatitis B Surface Antigens--immunology<br/>Hepatitis B Vaccines--administration & dosage<br/>Humans<br/>Immunization Schedule<br/>Male<br/>Middle Aged<br/>Renal Dialysis<br/>Vaccines, Synthetic--administration & dosage